APP and Alzheimer disease: In another model of AD, APPswe/PSEN1ΔE9 (APP/PS1) transgenic mice display progressive brain Aβ accumulation and behavioural impairments from 4 months of age, which become progressively apparent up to and beyond 12 months of age31–35.